Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Cancer Pain

• Buprenorphine for Cancer Pain
• Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds
• TEAS for the Treatment of Pain in Bone Metastases of Lung Cancer
• Early Treatment With Invasive Technique in Cancer Pain Management
• Phase Ⅰa Clinical Study of Hawthorn Red Pigment Combined With Standard Analgesic for Refractory Cancer Pain
• Epidural Association of Morphine and Ropivacaine for Cancer Pain Treatment
• Methadone for 'Adenocarcinopathic' Pain Treatment
• Efficacy of Duloxetine in Conjunction With Tramadol for Chronic Cancer Pain
• Dexmedetomidine in Splanchnic Nerve Neurolysis
• Pharmacokinetic and Pharmacodynamic Evaluation of Formulations of Δ9-THC
• 3D1002 in Combination With Oxycodone Hydrochloride Sustained-release Tablets in Patients With Moderate to Severe Cancer Pain
• Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control
• Proportional Dose of Sublingual Fentanyl Tablet Based on Daily Opioid Requirement
• PARASTOP - Paracetamol With Strong Opioids
• EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy
• NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers
• Endoscopic Ultrasound Guided Coeliac Plexus Neurolysis for Cancer Pain
• IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration
• Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients
• The Potential Protective Role of Venlafaxine Versus Memantine in Paclitaxel Induced Peripheral Neuropathy
• Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain
• Compare the Efficacy and Safety of Intranasal Esketamine in Chronic Opioid Refractory Pain
• Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain
• Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain
• Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain
• Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain
• Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration
• Oral Prednisolone Effect on Cancer WHO Stepladder Analgesia Protocol
• Safety and Efficacy of Inhaled Cannabis For the Uncontrolled Pain Relief in Patients With Advanced Cancer
• Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia
• A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain
• Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain
• Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain
• PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain
• Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients
• Methadone Associated With Morphine for Cancer Pain
• Study to Evaluate Safety and MTD of Epidural Resiniferatoxin Injection for Treatment of Intractable Cancer Pain
• Intranasal (NAS) Ketamine for Cancer Pain
• Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies
• An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion.
• Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy
• Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients
• GREAT - Good Response With Appropriate Treatment
• A Comparison of Morphine and Morphine Plus Dexmedetomidine in Chronic Cancer Pain
• Development of a Personalised Care Plan Designed to Reduce Chronic Post-Operative Pain Following Breast Surgery
• Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.
• Study of Opioid Rotation Versus Opioid Escalation in Patients With Moderate to Severe Cancer Pain
• Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain
• A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain
• Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
• Observational Registry Study of Quality of Life When Treating BTcP With Abstral
• IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
• Nasal Fentanyl for Chronic Cancer Pain
• Determine the Safety and Efficacy of Oxy/Nal Tablets Compared to Oxy PR in Subjects With Cancer Pain
• Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
• Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study
• RCT Comparing the Analgesic Efficacy of 4 Therapeutic Strategies Based on 4 Different Major Opioids (Fentanyl, Oxycodone, Buprenorphine vs Morphine) in Cancer Patients With Moderate/Severe Pain, at the Moment of Starting 3rd Step of WHO Analgesic La
• Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related Pain With Inadequate Pain Relief or Intolerable Side Effects When Treated With Level 3 Opioids.
• Efficacy Of Pregabalin In The Treatment Of Pancreatic Cancer Pain. A Randomized Controlled Double-Blind, Parallel Group Study
• PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
• Patient Satisfaction and Quality of Life Impact - PecFent®
• Patient Satisfaction and Quality of Life Impact - PecFent®
• Immediate-Release Oxycodone Capsules Study in Cancer Pain
• Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain
• Study to Evaluate Effectiveness and Tolerability of OROS Hydromorphone for Cancer Pain Treatment in Korean Patients
• Morphine as First Drug for Cancer Pain
• Magnesium Associated With Morphine for Cancer Pain Relief
• A Clinical Trial to Assess the Clinical Benefit of SSR411298 as Adjunctive Treatment for Persistent Cancer Pain
• Subcutaneous Lidocaine For Cancer-Related Pain
• Assessment of Efficacy and Safety in Relieving Opioid-induced Constipation in Patients With Cancer-related Pain
• Bicarbonate for Tumor Related Pain
• Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain
• A Comparative Study of KW-2246
• Paracetamol for Cancer Pain
• Tapentadol in Chronic Malignant Tumour Related Pain
• A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain
• The Effect of Cancer Pain Management Protocol on Hospitalized Cancer Patients: A Pilot Study
• Methadone Hydrochloride as First-Line Therapy in Treating Patients With Chronic Neuropathic Cancer Pain
• A Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Cancer-related Pain
• Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain
• Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients
• Safety of Fentanyl TAIFUN Treatment
• Phase 2 Study of Tapentadol Prolonged Release in Cancer Pain Participants
• A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hydromorphone Hydrochloride (HCl) With Morphine Sustain Release (SR) in Participants With Cancer Pain
• An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain
• An Efficacy and Safety Study of Hydromorphone Oral Osmotic System (OROS) in Korean Participants With Cancer Pain
• Opioids With or Without Olanzapine in Treating Patients With Moderate to Severe Cancer Pain
• A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients
• Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
• A Phase III Clinical Study of KW-2246
• Corticosteroids for Cancer Pain
• Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
• A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain
• An Efficacy and Safety Study of Fentanyl (JNS020QD) in Participants With Cancer Pain
• Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain
• A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion
• A Study to Evaluate the Safety and Effectiveness of Fentanyl-TTS Compared to Weak Opioids in Patients With Moderate to Severe Chronic Cancer Pain Previously Treated With NSAIDS (Non-steroidal Anti-inflammatory Drugs).
• Methadone Versus Morphine for Cancer-Related Pain
• Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain
• Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
• Switching From Morphine to Oral Methadone Plus Acetaminophen in the Treatment of Cancer Pain
• A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain
• A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
• Ketamine Associated With Opioids in Refractory Cancer Pain Treatment
• A Study to Evaluate Tapentadol (CG5503) in the Treatment of Chronic Tumor-Related Pain Compared With Placebo and Morphine
• Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids
• A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain
• Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain
• A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
• Oxycodone or Standard Pain Therapy in Treating Patients With Cancer Pain
• Clinical Study of KW-2246 in Patients With Cancer Pain
• Analgesia and Wound Healing Assessment Following Topical Morphine Applied to Patients With Cutaneous Cancer Related Pain
• Efficacy and Safety of FITpatch Compared to Standard Opioid Treatment in Cancer Pain (FT-015-IN)
• Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain
• Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -
• Acetaminophen for Cancer Pain
• Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects
• Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain
• The Pain Pen for Breakthrough Cancer Pain
• Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
• Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
• Marijuana for Cancer Pain